<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>9 3 What is the Question | Notebook|笔记本</title>
  <meta name="description" content="9 3 What is the Question | Notebook|笔记本" />
  <meta name="generator" content="bookdown 0.20 and GitBook 2.6.7" />

  <meta property="og:title" content="9 3 What is the Question | Notebook|笔记本" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="9 3 What is the Question | Notebook|笔记本" />
  
  
  

<meta name="author" content="Caleb Jin|金时强" />



  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="ethical-issues.html"/>
<link rel="next" href="references.html"/>
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />











<style type="text/css">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">金时强的笔记本</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> Prologue</a></li>
<li class="chapter" data-level="2" data-path="stats.html"><a href="stats.html"><i class="fa fa-check"></i><b>2</b> Statistics</a><ul>
<li class="chapter" data-level="2.1" data-path="stats.html"><a href="stats.html#bayesian-linear-model"><i class="fa fa-check"></i><b>2.1</b> Bayesian Linear Model</a></li>
<li class="chapter" data-level="2.2" data-path="stats.html"><a href="stats.html#project-1"><i class="fa fa-check"></i><b>2.2</b> Project 1</a></li>
<li class="chapter" data-level="2.3" data-path="stats.html"><a href="stats.html#project-2"><i class="fa fa-check"></i><b>2.3</b> Project 2</a></li>
<li class="chapter" data-level="2.4" data-path="stats.html"><a href="stats.html#project-3"><i class="fa fa-check"></i><b>2.4</b> Project 3</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="coding.html"><a href="coding.html"><i class="fa fa-check"></i><b>3</b> Coding</a><ul>
<li class="chapter" data-level="3.1" data-path="coding.html"><a href="coding.html#python"><i class="fa fa-check"></i><b>3.1</b> Python</a></li>
<li class="chapter" data-level="3.2" data-path="coding.html"><a href="coding.html#mysql"><i class="fa fa-check"></i><b>3.2</b> MySQL</a></li>
<li class="chapter" data-level="3.3" data-path="coding.html"><a href="coding.html#r"><i class="fa fa-check"></i><b>3.3</b> R</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="english.html"><a href="english.html"><i class="fa fa-check"></i><b>4</b> English</a><ul>
<li class="chapter" data-level="4.1" data-path="english.html"><a href="english.html#suits-season-1-episode-1"><i class="fa fa-check"></i><b>4.1</b> Suits-Season 1-Episode 1</a><ul>
<li class="chapter" data-level="4.1.1" data-path="english.html"><a href="english.html#vacabulary-sentense"><i class="fa fa-check"></i><b>4.1.1</b> Vacabulary &amp; Sentense</a></li>
</ul></li>
<li class="chapter" data-level="4.2" data-path="english.html"><a href="english.html#bible"><i class="fa fa-check"></i><b>4.2</b> Bible</a><ul>
<li class="chapter" data-level="4.2.1" data-path="english.html"><a href="english.html#matthew"><i class="fa fa-check"></i><b>4.2.1</b> Matthew</a></li>
<li class="chapter" data-level="4.2.2" data-path="english.html"><a href="english.html#luke"><i class="fa fa-check"></i><b>4.2.2</b> Luke</a></li>
<li class="chapter" data-level="4.2.3" data-path="english.html"><a href="english.html#names"><i class="fa fa-check"></i><b>4.2.3</b> Names</a></li>
</ul></li>
<li class="chapter" data-level="4.3" data-path="english.html"><a href="english.html#writing"><i class="fa fa-check"></i><b>4.3</b> Writing</a><ul>
<li class="chapter" data-level="4.3.1" data-path="english.html"><a href="english.html#formal-writing"><i class="fa fa-check"></i><b>4.3.1</b> formal writing</a></li>
<li class="chapter" data-level="4.3.2" data-path="english.html"><a href="english.html#email-writing"><i class="fa fa-check"></i><b>4.3.2</b> email writing</a></li>
</ul></li>
<li class="chapter" data-level="4.4" data-path="english.html"><a href="english.html#others"><i class="fa fa-check"></i><b>4.4</b> others</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="recipe.html"><a href="recipe.html"><i class="fa fa-check"></i><b>5</b> Recipe</a><ul>
<li class="chapter" data-level="5.1" data-path="recipe.html"><a href="recipe.html#example-one"><i class="fa fa-check"></i><b>5.1</b> Example one</a></li>
<li class="chapter" data-level="5.2" data-path="recipe.html"><a href="recipe.html#example-two"><i class="fa fa-check"></i><b>5.2</b> Example two</a></li>
</ul></li>
<li class="chapter" data-level="6" data-path="recitation.html"><a href="recitation.html"><i class="fa fa-check"></i><b>6</b> Recitation</a><ul>
<li class="chapter" data-level="6.1" data-path="recitation.html"><a href="recitation.html#good-verses"><i class="fa fa-check"></i><b>6.1</b> Good verses</a></li>
<li class="chapter" data-level="6.2" data-path="recitation.html"><a href="recitation.html#good-chapters"><i class="fa fa-check"></i><b>6.2</b> Good chapters</a></li>
</ul></li>
<li class="chapter" data-level="7" data-path="intro.html"><a href="intro.html"><i class="fa fa-check"></i><b>7</b> [1] Introduction to Clinical Trials</a><ul>
<li class="chapter" data-level="7.1" data-path="intro.html"><a href="intro.html#fundamental-point"><i class="fa fa-check"></i><b>7.1</b> Fundamental Point</a></li>
<li class="chapter" data-level="7.2" data-path="intro.html"><a href="intro.html#what-is-a-clinical-trial"><i class="fa fa-check"></i><b>7.2</b> What Is a Clinical Trial?</a></li>
<li class="chapter" data-level="7.3" data-path="intro.html"><a href="intro.html#clinical-trial-phase"><i class="fa fa-check"></i><b>7.3</b> Clinical Trial Phase</a><ul>
<li class="chapter" data-level="7.3.1" data-path="intro.html"><a href="intro.html#phase-i-studies"><i class="fa fa-check"></i><b>7.3.1</b> Phase I Studies</a></li>
<li class="chapter" data-level="7.3.2" data-path="intro.html"><a href="intro.html#phase-iiiiv-studies"><i class="fa fa-check"></i><b>7.3.2</b> Phase III/IV Studies</a></li>
</ul></li>
<li class="chapter" data-level="7.4" data-path="intro.html"><a href="intro.html#why-are-clinical-trials-needed"><i class="fa fa-check"></i><b>7.4</b> Why Are Clinical Trials Needed?</a></li>
<li class="chapter" data-level="7.5" data-path="intro.html"><a href="intro.html#problems-in-the-timing-of-a-trial"><i class="fa fa-check"></i><b>7.5</b> Problems in the Timing of a Trial</a></li>
<li class="chapter" data-level="7.6" data-path="intro.html"><a href="intro.html#study-protocol"><i class="fa fa-check"></i><b>7.6</b> Study Protocol</a></li>
</ul></li>
<li class="chapter" data-level="8" data-path="ethical-issues.html"><a href="ethical-issues.html"><i class="fa fa-check"></i><b>8</b> [2] Ethical Issues</a><ul>
<li class="chapter" data-level="8.1" data-path="ethical-issues.html"><a href="ethical-issues.html#fundamental-point-1"><i class="fa fa-check"></i><b>8.1</b> Fundamental Point</a></li>
<li class="chapter" data-level="8.2" data-path="ethical-issues.html"><a href="ethical-issues.html#planning-and-design"><i class="fa fa-check"></i><b>8.2</b> Planning and Design</a><ul>
<li class="chapter" data-level="8.2.1" data-path="ethical-issues.html"><a href="ethical-issues.html#ethics-training"><i class="fa fa-check"></i><b>8.2.1</b> Ethics Training</a></li>
<li class="chapter" data-level="8.2.2" data-path="ethical-issues.html"><a href="ethical-issues.html#does-the-question-require-a-clinical-trial"><i class="fa fa-check"></i><b>8.2.2</b> Does the Question Require a Clinical Trial?</a></li>
<li class="chapter" data-level="8.2.3" data-path="ethical-issues.html"><a href="ethical-issues.html#randomization"><i class="fa fa-check"></i><b>8.2.3</b> Randomization</a></li>
<li class="chapter" data-level="8.2.4" data-path="ethical-issues.html"><a href="ethical-issues.html#control-group"><i class="fa fa-check"></i><b>8.2.4</b> Control Group</a></li>
<li class="chapter" data-level="8.2.5" data-path="ethical-issues.html"><a href="ethical-issues.html#protection-from-conflicts-of-interest"><i class="fa fa-check"></i><b>8.2.5</b> Protection from Conflicts of Interest</a></li>
<li class="chapter" data-level="8.2.6" data-path="ethical-issues.html"><a href="ethical-issues.html#informed-consent"><i class="fa fa-check"></i><b>8.2.6</b> Informed Consent</a></li>
</ul></li>
<li class="chapter" data-level="8.3" data-path="ethical-issues.html"><a href="ethical-issues.html#conduct"><i class="fa fa-check"></i><b>8.3</b> Conduct</a><ul>
<li class="chapter" data-level="8.3.1" data-path="ethical-issues.html"><a href="ethical-issues.html#trials-in-low--and-middle-income-countries"><i class="fa fa-check"></i><b>8.3.1</b> Trials in Low- and Middle-Income Countries</a></li>
<li class="chapter" data-level="8.3.2" data-path="ethical-issues.html"><a href="ethical-issues.html#recruitment"><i class="fa fa-check"></i><b>8.3.2</b> Recruitment</a></li>
<li class="chapter" data-level="8.3.3" data-path="ethical-issues.html"><a href="ethical-issues.html#safety-and-efficacy-monitoring"><i class="fa fa-check"></i><b>8.3.3</b> Safety and Efficacy Monitoring</a></li>
<li class="chapter" data-level="8.3.4" data-path="ethical-issues.html"><a href="ethical-issues.html#early-termination-for-other-than-scientific"><i class="fa fa-check"></i><b>8.3.4</b> Early Termination for Other Than Scientific</a></li>
</ul></li>
<li class="chapter" data-level="8.4" data-path="ethical-issues.html"><a href="ethical-issues.html#or-safety-reasons"><i class="fa fa-check"></i><b>8.4</b> or Safety Reasons</a><ul>
<li class="chapter" data-level="8.4.1" data-path="ethical-issues.html"><a href="ethical-issues.html#privacy-and-confidentiality"><i class="fa fa-check"></i><b>8.4.1</b> Privacy and Confidentiality</a></li>
<li class="chapter" data-level="8.4.2" data-path="ethical-issues.html"><a href="ethical-issues.html#data-falsification"><i class="fa fa-check"></i><b>8.4.2</b> Data Falsification</a></li>
</ul></li>
<li class="chapter" data-level="8.5" data-path="ethical-issues.html"><a href="ethical-issues.html#reporting"><i class="fa fa-check"></i><b>8.5</b> Reporting</a><ul>
<li class="chapter" data-level="8.5.1" data-path="ethical-issues.html"><a href="ethical-issues.html#publication-bias-suppression-and-delays"><i class="fa fa-check"></i><b>8.5.1</b> Publication Bias, Suppression, and Delays</a></li>
<li class="chapter" data-level="8.5.2" data-path="ethical-issues.html"><a href="ethical-issues.html#conflicts-of-interest-and-publication"><i class="fa fa-check"></i><b>8.5.2</b> Conflicts of Interest and Publication</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="9" data-path="what-is-the-question.html"><a href="what-is-the-question.html"><i class="fa fa-check"></i><b>9</b> 3 What is the Question</a><ul>
<li class="chapter" data-level="9.1" data-path="what-is-the-question.html"><a href="what-is-the-question.html#fundamental-point-2"><i class="fa fa-check"></i><b>9.1</b> Fundamental Point</a></li>
<li class="chapter" data-level="9.2" data-path="what-is-the-question.html"><a href="what-is-the-question.html#selection-of-the-questions"><i class="fa fa-check"></i><b>9.2</b> Selection of the Questions</a><ul>
<li class="chapter" data-level="9.2.1" data-path="what-is-the-question.html"><a href="what-is-the-question.html#primary-question"><i class="fa fa-check"></i><b>9.2.1</b> Primary Question</a></li>
<li class="chapter" data-level="9.2.2" data-path="what-is-the-question.html"><a href="what-is-the-question.html#secondary-questions-regarding-benefit"><i class="fa fa-check"></i><b>9.2.2</b> Secondary Questions Regarding Benefit</a></li>
<li class="chapter" data-level="9.2.3" data-path="what-is-the-question.html"><a href="what-is-the-question.html#questions-regarding-harm"><i class="fa fa-check"></i><b>9.2.3</b> Questions Regarding Harm</a></li>
<li class="chapter" data-level="9.2.4" data-path="what-is-the-question.html"><a href="what-is-the-question.html#ancillary-questions"><i class="fa fa-check"></i><b>9.2.4</b> Ancillary Questions</a></li>
</ul></li>
<li class="chapter" data-level="9.3" data-path="what-is-the-question.html"><a href="what-is-the-question.html#kinds-of-trials"><i class="fa fa-check"></i><b>9.3</b> Kinds of Trials</a></li>
<li class="chapter" data-level="9.4" data-path="what-is-the-question.html"><a href="what-is-the-question.html#superiority-vs.-noninferiority-trials"><i class="fa fa-check"></i><b>9.4</b> Superiority vs. Noninferiority Trials</a><ul>
<li class="chapter" data-level="9.4.1" data-path="what-is-the-question.html"><a href="what-is-the-question.html#comparative-effectiveness-trials"><i class="fa fa-check"></i><b>9.4.1</b> Comparative Effectiveness Trials</a></li>
</ul></li>
<li class="chapter" data-level="9.5" data-path="what-is-the-question.html"><a href="what-is-the-question.html#intervention"><i class="fa fa-check"></i><b>9.5</b> Intervention</a></li>
<li class="chapter" data-level="9.6" data-path="what-is-the-question.html"><a href="what-is-the-question.html#response-variables"><i class="fa fa-check"></i><b>9.6</b> Response Variables</a><ul>
<li class="chapter" data-level="9.6.1" data-path="what-is-the-question.html"><a href="what-is-the-question.html#kinds-of-response-variables"><i class="fa fa-check"></i><b>9.6.1</b> Kinds of Response Variables</a></li>
<li class="chapter" data-level="9.6.2" data-path="what-is-the-question.html"><a href="what-is-the-question.html#specifying-the-question"><i class="fa fa-check"></i><b>9.6.2</b> Specifying the Question</a></li>
<li class="chapter" data-level="9.6.3" data-path="what-is-the-question.html"><a href="what-is-the-question.html#biomarkers-and-surrogate-response-variables"><i class="fa fa-check"></i><b>9.6.3</b> Biomarkers and Surrogate Response Variables</a></li>
</ul></li>
<li class="chapter" data-level="9.7" data-path="what-is-the-question.html"><a href="what-is-the-question.html#changing-the-question"><i class="fa fa-check"></i><b>9.7</b> Changing the Question</a></li>
<li class="chapter" data-level="9.8" data-path="what-is-the-question.html"><a href="what-is-the-question.html#general-comments"><i class="fa fa-check"></i><b>9.8</b> General Comments</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Caleb's notebook</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Notebook|笔记本</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="what-is-the-question" class="section level1">
<h1><span class="header-section-number">9</span> 3 What is the Question</h1>
<p>They addressed the straight-forward question of whether the new treatment was beneficial, neutral, or harmful compared to placebo or nothing. Since that time, the best medical care has
improved dramatically, probably largely due to the contribution of randomized clinical trials.</p>
<div id="fundamental-point-2" class="section level2">
<h2><span class="header-section-number">9.1</span> Fundamental Point</h2>
<p>Each clinical trial must have a primary question. The primary question, as well as
any secondary or subsidiary questions, should be carefully selected, clearly
defined, and stated in advance.</p>
</div>
<div id="selection-of-the-questions" class="section level2">
<h2><span class="header-section-number">9.2</span> Selection of the Questions</h2>
<div id="primary-question" class="section level3">
<h3><span class="header-section-number">9.2.1</span> Primary Question</h3>
<ul>
<li>The primary question should be the one the investigators and sponsors are
most interested in answering and that is capable of being adequately answered.</li>
</ul>
<p>It is the question upon which the sample size of the study is based, and which must
be emphasized in the reporting of the trial results. The primary question may
be framed in the form of testing a hypothesis because most of the time an
intervention is postulated to have a particular outcome which, on the average,
will be different from (or, in the case of noninferiority trials, not worse than) the
outcome in a control group</p>
</div>
<div id="secondary-questions-regarding-benefit" class="section level3">
<h3><span class="header-section-number">9.2.2</span> Secondary Questions Regarding Benefit</h3>
<ul>
<li><p>There may also be a variety of subsidiary, or secondary questions that are usually
related to the primary question.</p></li>
<li><p>They can be of two types.</p>
<ul>
<li>In the first, the response variable is different than that in the primary question. For example, the primary question might ask whether mortality from any cause is altered by
the intervention. Secondary questions might relate to incidence of cause-specific
death (such as cancer mortality), incidence of non-fatal renal failure, or incidence of
stroke.</li>
<li>The second type of secondary question relates to <strong>subgroup hypotheses</strong>. For
example, in a study of cancer therapy, the investigator may want to look specifically
at people by gender, age, stage of disease at entry into the trial or by presence or
absence of a particular biomarker or genetic marker.</li>
</ul></li>
<li><p>Generally, the most useful reasons for considering subgroups
are to examine consistency of results across pre-defined subgroups and to create
hypotheses that can be tested in future trials and meta-analyses.</p></li>
<li><p>Generally, the most useful reasons for considering subgroups are to examine consistency of results across pre-defined subgroups and to create hypotheses that can be tested in future trials and meta-analyses.</p></li>
</ul>
</div>
<div id="questions-regarding-harm" class="section level3">
<h3><span class="header-section-number">9.2.3</span> Questions Regarding Harm</h3>
<ul>
<li>Important questions that can be answered by clinical trials concern adverse effects
of or reactions to therapy</li>
</ul>
</div>
<div id="ancillary-questions" class="section level3">
<h3><span class="header-section-number">9.2.4</span> Ancillary Questions</h3>
</div>
</div>
<div id="kinds-of-trials" class="section level2">
<h2><span class="header-section-number">9.3</span> Kinds of Trials</h2>
</div>
<div id="superiority-vs.-noninferiority-trials" class="section level2">
<h2><span class="header-section-number">9.4</span> Superiority vs. Noninferiority Trials</h2>
<p>With the development of effective therapies, many trials have been designed to
demonstrate that a new intervention is not worse than the intervention previously
shown to be beneficial, i.e., an active control, by some prespecified amount.
As noted earlier, the motivation for such a question is that the new intervention
might not be better than standard treatment on the primary or important secondary
outcomes, but may be less toxic, more convenient, less invasive and/or have some
other attractive feature, including lower cost. The challenge is to define what is
meant by “not worse than.” This has been referred to as the “margin of indifference,” or <span class="math inline">\(\delta\)</span>, meaning that if the new intervention is not less effective than this
margin, its use might be of value given the other features. In the analysis of this
design, the 95% upper confidence limit would need to be less than this margin in
order to claim noninferiority.</p>
<div id="comparative-effectiveness-trials" class="section level3">
<h3><span class="header-section-number">9.4.1</span> Comparative Effectiveness Trials</h3>
<p>when new interventions are developed, they must be compared against existing therapy. Additionally, the increasing cost burden of medical care means that even if several treatments are equally effective, we need to consider factors such as cost, tolerability, and ease of administration. Therefore, comparative effectiveness trials are commonly of the noninferiority sort.</p>
</div>
</div>
<div id="intervention" class="section level2">
<h2><span class="header-section-number">9.5</span> Intervention</h2>
<ul>
<li><p>First, the potential benefit of the intervention must be maximized, while possible
harm is kept to a minimum.</p></li>
<li><p>Second, the availability of the drug or device for testing needs to be determined.
If it is not yet licensed, special approval from the regulatory agency and cooperation
or support by the manufacturer are required.</p></li>
<li><p>Third, investigators must take into account design aspects, such as time of
initiation and duration of the intervention, need for special tests or laboratory
facilities, and the logistics of blinding in the case of drug studies.</p></li>
</ul>
</div>
<div id="response-variables" class="section level2">
<h2><span class="header-section-number">9.6</span> Response Variables</h2>
<div id="kinds-of-response-variables" class="section level3">
<h3><span class="header-section-number">9.6.1</span> Kinds of Response Variables</h3>
</div>
<div id="specifying-the-question" class="section level3">
<h3><span class="header-section-number">9.6.2</span> Specifying the Question</h3>
</div>
<div id="biomarkers-and-surrogate-response-variables" class="section level3">
<h3><span class="header-section-number">9.6.3</span> Biomarkers and Surrogate Response Variables</h3>
</div>
</div>
<div id="changing-the-question" class="section level2">
<h2><span class="header-section-number">9.7</span> Changing the Question</h2>
</div>
<div id="general-comments" class="section level2">
<h2><span class="header-section-number">9.8</span> General Comments</h2>

</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="ethical-issues.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="references.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["NotesEnsemble.pdf", "NotesEnsemble.epub"],
"toc": {
"collapse": "subsection"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
